Healthy subjects
Conditions
Sponsors
HUMA R&D CORP
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1)Japanese men and women aged 30 to younger than 50 at the time of informed consent 2)Non smoker 3)A person who has received sufficient explanation of the purpose and content of the research, is capable of giving informed consent, voluntarily volunteers to participate in the research, and consents to participate in the research in writing.
Exclusion criteria
Exclusion criteria: 1)Patients currently receiving any type of drug or outpatient treatment 2)Subjects who are currently receiving exercise or dietary therapy under the supervision of a physician. 3)Persons with a history or current or concurrent liver disease or serious renal, endocrine, cardiovascular, gastrointestinal, pulmonary, hematologic, or metabolic disease. 4)Patients with a history of drug or food allergy 5)Those who wish to do so during pregnancy, lactation, or the duration of the study. 6)Persons with serious or past brain diseases. 7)Subjects who have received blood donations or vaccinations within the previous 3 months or have scheduled them during the study period. 8)People who routinely consume health foods, supplements, and medicines that may affect concentration 9)Persons with a history of psychiatric disorders (e.g., depression), sleep disorders, or psychiatric disorders in the past. 10)Alcoholism, substance abuse, or substance abuse with treatment or a history of treatment. 11)Employees working during night shifts, etc. 12)Excessively irregular lifestyle such as eating or sleeping 13)Subjects who have participated in other clinical studies or have participated in other clinical studies within the previous 3 months. 14)Persons who are difficult to comply with the records of various surveys 15)Other than the above, the principal investigator judged that the subject was ineligible for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitrax,Uchida Kraepelin test | — |
Secondary
| Measure | Time frame |
|---|---|
| POMS2 shorter version,VAS questionnaire,Salivary marker | — |
Countries
Japan
Contacts
Public ContactOchitani Daisuke
HUMA R&D CORP Clinical Development Division
Outcome results
None listed